SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-068411
Filing Date
2022-11-02
Accepted
2022-11-02 07:39:41
Documents
3
Period of Report
2022-11-02

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea167922-6k_purplebiotech.htm 6-K 13720
2 PURPLE BIOTECH APPOINTS LIOR FHIMA AS CHIEF FINANCIAL OFFICER ea167922ex99-1_purplebio.htm EX-99.1 13510
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2488
  Complete submission text file 0001213900-22-068411.txt   32029
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 221352312
SIC: 2834 Pharmaceutical Preparations